Merck Acquires Microbiology Business of Biotest AG

  • Author: ChemistryViews
  • Published: 23 March 2011
  • Source / Publisher: Merck KGaA
  • Associated Suppliers: Merck KGaA, Darmstadt, Germany
thumbnail image: Merck Acquires Microbiology Business of Biotest AG

Merck KGaA announced today that it has entered into a definitive agreement to acquire the microbiology business of Biotest AG, Dreieich, Germany. This business comprises heipha Dr. Müller GmbH, located in Eppelheim, Germany, as well as the Hycon business located in Dreieich, the subsidiaries in France, Japan and in the USA as well as further activities and employees in several European countries. In all, the business has approximately 290 employees and sales of approximately EUR 50 million in 2010. The agreement is subject to antitrust approvals in Germany and Austria. Closing of the transaction is expected in the second half of 2011.

The acquisition allows the Merck Millipore division to complete its product portfolio in the attractive growth segment industrial microbiology for contamination detection. It is planned to integrate Biotest’s microbiology activities into Merck Millipore’s Lab Solutions business unit.

Article Views: 3065

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from, please contact us first for permission. more

CONNECT: on Facebook on Twitter on YouTube on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH